Old Hepatitis B Mystery Unveils Promising New Treatment In their effort to answer a decades-old biological question about how ...

The Pennsylvania-based drugmaker expects between $820 million and $860 million this year from WAKIX, as it pushes its ...

Jeffrey Dayno; President, Chief Executive Officer, Director; Harmony Biosciences Holdings Inc Jeffrey Dierks; Chief Commercial Officer; Harmony Biosciences Holdings Inc Kumar Budur; EVP and Chief ...

Mirum Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CTEXLItm (chenodiol) tablets, a bile acid, for the treatment of adults with cerebrotendinous ...

Reports Q4 revenue $ $201.27M, consensus $201.25M…GAAP net income for the quarter ended December 31, was $49.5M, or 85c earnings per diluted ...

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the fourth quarter and year-end 2024 and ...

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced record-breaking financial results for 2024, driven by robust ...

Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at ...

New Delhi: World Rare Disease Day is observed on the last day of February to raise awareness about rare diseases and their ...